No evidence of xenotropic murine leukemia virus-related virus transmission by blood transfusion from infected rhesus macaques

Journal of Virology

Volumn 87, Issue 4, 2013, Pages 2278-2286

  Williams, Dhanya K ^a   Galvin, Teresa A ^a   Gao, Yamei ^a   O'Neill, Christina ^a,b   Glasner, Dustin ^a   Khan, Arifa S ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY; VIRUS DNA;

ACUTE PHASE RESPONSE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; BLOODSTREAM INFECTION; CONTROLLED STUDY; DNA SEQUENCE; ENVELOPE GENE; GROUP SPECIFIC ANTIGEN GENE; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROVIRUS INFECTION; RHESUS MONKEY; VIRUS CULTURE; VIRUS GENE; VIRUS INHIBITION; VIRUS ISOLATION; VIRUS MUTATION; VIRUS REPLICATION; VIRUS TRANSMISSION; WESTERN BLOTTING; XENOTROPIC MULV RELATED VIRUS;

ANIMALS; ANTIBODIES, VIRAL; BLOOD TRANSFUSION; BLOTTING, WESTERN; CELLS, CULTURED; COCULTURE TECHNIQUES; DNA, VIRAL; MACACA MULATTA; POLYMERASE CHAIN REACTION; RETROVIRIDAE INFECTIONS; SEQUENCE ANALYSIS, DNA; XENOTROPIC MURINE LEUKEMIA VIRUS-RELATED VIRUS;

EID: 84873813732     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02326-12     Document Type: Article

References (52)

1. Urisman A, Molinaro RJ, Fischer N, Plummer SJ, Casey G, Klein EA, Malathi K, Magi-Galluzzi C, Tubbs RR, Ganem D, Silverman RH, DeRisi JL. 2006. Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog. 2:e25. doi:10.1371/journal.ppat.0020025.
2. Lombardi VC, Ruscetti FW, Das Gupta J, Pfost MA, Hagen KS, Peterson DL, Ruscetti SK, Bagni RK, Petrow-Sadowski C, Gold B, Dean M, Silverman RH, Mikovits JA. 2009. Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 326:585-589.
3. Brooks J, Lycett-Lambert K, Caminiti K, Merks H, McMillan R, Sandstrom P. 2012. No evidence of cross-species transmission of mouse retroviruses to animal workers exposed to mice. Transfusion 52:317-325.
4. Blomberg J, Blomberg F, Sjosten A, Sheikholvaezin A, Bolin-Wiener A, Elfaitouri A, Hessel S, Gottfries CG, Zachrisson O, Ohrmalm C, Jobs M, Pipkorn R. 2012. No evidence for xenotropic murine leukemia-related virus infection in Sweden using internally controlled multiepitope suspension array serology. Clin. Vaccine Immunol. 19:1399-1410.
5. Dodd RY, Hackett J, Jr, Linnen JM, Dorsey K, Wu Y, Zou S, Qiu X, Swanson P, Schochetman G, Gao K, Carrick JM, Krysztof DE, Stramer SL. 2012. Xenotropic murine leukemia virus-related virus does not pose a risk to blood recipient safety. Transfusion 52:298 -306.
6. Klein HG, Dodd RY, Hollinger FB, Katz LM, Kleinman S, McCleary KK, Silverman RH, Stramer SL. 2011. Xenotropic murine leukemia virus-related virus (XMRV) and blood transfusion: report of the AABB interorganizational XMRV task force. Transfusion 51:654-661.
7. Kleinman S, King MR, Busch MP, Murphy EL, Glynn SA. 2012. The National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Studies (Retrovirus Epidemiology Donor Study and Retrovirus Epidemiology Donor Study-II): twenty years of research to advance blood product safety and availability. Transfus. Med. Rev. 26:281-304.
8. Mi Z, Lu Y, Zhang S, An X, Wang X, Chen B, Wang Q, Tong Y. 2012. Absence of xenotropic murine leukemia virus-related virus in blood donors in China. Transfusion 52:326 -331.
9. Qiu X, Swanson P, Tang N, Leckie GW, Devare SG, Schochetman G, Hackett J, Jr. 2012. Seroprevalence of xenotropic murine leukemia virusrelated virus in normal and retrovirus-infected blood donors. Transfusion 52:307-316.
10. Simmons G, Glynn SA, Holmberg JA, Coffin JM, Hewlett IK, Lo SC, Mikovits JA, Switzer WM, Linnen JM, Busch MP. 2011. The Blood Xenotropic Murine Leukemia Virus-Related Virus Scientific Research Working Group: mission, progress, and plans. Transfusion 51:643- 653.
11. Tang S, Zhao J, Viswanath R, Nyambi PN, Redd AD, Dastyar A, Spacek LA, Quinn TC, Wang X, Wood O, Gaddam D, Devadas K, Hewlett IK. 2011. Absence of detectable xenotropic murine leukemia virus-related virus in plasma or peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected blood donors or individuals in Africa. Transfusion 51:463- 468.
12. Erlwein O, Robinson MJ, Kaye S, Wills G, Izui S, Wessely S, Weber J, Cleare A, Collier D, McClure MO. 2011. Investigation into the presence of and serological response toXMRVin CFS patients. PLoS One 6:e17592. doi:10.1371/journal.pone.0017592.
13. Kearney MF, Spindler J, Wiegand A, Shao W, Anderson EM, Maldarelli F, Ruscetti FW, Mellors JW, Hughes SH, Le Grice SF, Coffin JM. 2012. Multiple sources of contamination in samples from patients reported to have XMRV infection. PLoS One 7:e30889. doi:10.1371/journal.pone.0030889.
14. Oakes B, Tai AK, Cingoz O, Henefield MH, Levine S, Coffin JM, Huber BT. 2010. Contamination of human DNA samples with mouse DNA can lead to false detection of XMRV-like sequences. Retrovirology 7:109. doi: 10.1186/1742-4690-7-109.
15. Robinson MJ, Erlwein OW, Kaye S, Weber J, Cingoz O, Patel A, Walker MM, Kim WJ, Uiprasertkul M, Coffin JM, McClure MO. 2010. Mouse DNA contamination in human tissue tested for XMRV. Retrovirology 7:108. doi:10.1186/1742-4690-7-108.
16. Sato E, Furuta RA, Miyazawa T. 2010. An endogenous murine leukemia viral genome contaminant in a commercial RT-PCR kit is amplified using standard primers for XMRV. Retrovirology 7:110. doi:10.1186/1742-4690 -7-110.
17. Sfanos KS, Aloia AL, De Marzo AM, Rein A. 2012. XMRV and prostate cancer-a 'final' perspective. Nat. Rev. Urol. 9:111-118.
18. Silverman RH, Das Gupta J, Lombardi VC, Ruscetti FW, Pfost MA, Hagen KS, Peterson DL, Ruscetti SK, Bagni RK, Petrow-Sadowski C, Gold B, Dean M, Mikovits JA. 2011. Partial retraction. Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 334:176. doi:10.1126/science.334.6053.176-a.
19. Tuke PW, Tettmar KI, Tamuri A, Stoye JP, Tedder RS. 2011. PCR master mixes harbour murine DNA sequences. Caveat emptor! PLoS One 6:e19953. doi:10.1371/journal.pone.0019953.
20. Knouf EC, Metzger MJ, Mitchell PS, Arroyo JD, Chevillet JR, Tewari M, Miller AD. 2009. Multiple integrated copies and high-level production of the human retrovirus XMRV (xenotropic murine leukemia virus-related virus) from 22Rv1 prostate carcinoma cells. J. Virol. 83:7353-7356.
21. Paprotka T, Delviks-Frankenberry KA, Cingoz O, Martinez A, Kung HJ, Tepper CG, Hu WS, Fivash MJ, Jr, Coffin JM, Pathak VK. 2011. Recombinant origin of the retrovirus XMRV. Science 333:97-101.
22. Robinson MJ, Erlwein O, McClure MO. 2011. Xenotropic murine leukaemia virus-related virus (XMRV) does not cause chronic fatigue. Trends Microbiol. 19:525-529.
23. Metzger MJ, Holguin CJ, Mendoza R, Miller AD. 2010. The prostate cancer-associated human retrovirus XMRV lacks direct transforming activity but can induce low rates of transformation in cultured cells. J. Virol. 84:1874 -1880.
24. Curriu M, Carrillo J, Massanella M, Garcia E, Cunyat F, Pena R, Wienberg P, Carrato C, Areal J, Bofill M, Clotet B, Blanco J, Cabrera C. 2012. Susceptibility of human lymphoid tissue cultured ex vivo to xenotropic murine leukemia virus-related virus (XMRV) infection. PLoS One 7:e37415. doi:10.1371/journal.pone.0037415.
25. Ravichandran V, Major EO, Ibe C, Monaco MC, Girisetty MK, Hewlett IK. 2011. Susceptibility of human primary neuronal cells to xenotropic murine leukemia virus-related (XMRV) virus infection. Virol. J. 8:443. doi:10.1186/1743-422X-8-443.
26. Rodriguez JJ, Goff SP. 2010. Xenotropic murine leukemia virus-related virus establishes an efficient spreading infection and exhibits enhanced transcriptional activity in prostate carcinoma cells. J. Virol. 84:2556 -2562.
27. Stieler K, Schulz C, Lavanya M, Aepfelbacher M, Stocking C, Fischer N. 2010. Host range and cellular tropism of the human exogenous gammaretrovirus XMRV. Virology 399:23-30.
28. Onlamoon N, Das Gupta J, Sharma P, Rogers K, Suppiah S, Rhea J, Molinaro RJ, Gaughan C, Dong B, Klein EA, Qiu X, Devare S, Schochetman G, Hackett J, Jr, Silverman RH, Villinger F. 2011. Infection, viral dissemination, and antibody responses of rhesus macaques exposed to the human gammaretrovirus XMRV. J. Virol. 85:4547-4557.
29. Sakuma T, Tonne JM, Squillace KA, Ohmine S, Thatava T, Peng KW, Barry MA, Ikeda Y. 2011. Early events in retrovirus XMRV infection of the wild-derived mouse Mus pahari. J. Virol. 85:1205-1213.
30. Sakuma T, Tonne JM, Malcolm JA, Thatava T, Ohmine S, Peng KW, Ikeda Y. 2012. Long-term infection and vertical transmission of a gammaretrovirus in a foreign host species. PLoS One 7:e29682. doi:10.1371/journal.pone.0029682.
31. Switzer WM, Zheng H, Simmons G, Zhou Y, Tang S, Shankar A, Kapusinszky B, Delwart EL, Heneine W. 2011. No evidence of murine leukemia virus-related viruses in live attenuated human vaccines. PLoS One 6:e29223. doi:10.1371/journal.pone.0029223.
32. Williams DK, Galvin TA, Ma H, Khan AS. 2011. Investigation of xenotropic murine leukemia virus-related virus (XMRV) in human and other cell lines. Biologicals 39:378 -383.
33. Ma YK, Khan AS. 2009. Evaluation of different RT enzyme standards for quantitation of retroviruses using the single-tube fluorescent productenhanced reverse transcriptase assay. J. Virol. Methods 157:133-140.
34. Khan AS, Sears JF, Muller J, Galvin TA, Shahabuddin M. 1999. Sensitive assays for isolation and detection of simian foamy retroviruses. J. Clin. Microbiol. 37:2678-2686.
35. Karber GA. 1931. A contribution to the collective treatment of a pharmacological experimental series. Arch. Exp. Pathol. Pharmakol. 162:480-483.
36. Khan AS, Kumar D. 2006. Simian foamy virus infection by whole-blood transfer in rhesus macaques: potential for transfusion transmission in humans. Transfusion 46:1352-1359.
37. National Research Council. 1996. Guide for the care and use of laboratory animals. National Academies Press, Washington, DC.
38. Williams DK, Khan AS. 2010. Role of neutralizing antibodies in controlling simian foamy virus transmission and infection. Transfusion 50:200-207.
39. Donahue RE, Kessler SW, Bodine D, McDonagh K, Dunbar C, Goodman S, Agricola B, Byrne E, Raffeld M, Moen R, Bacher J, Zsebo KM, Nienhuis AW. 1992. Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J. Exp. Med. 176:1125-1135.
40. Del Prete GQ, Kearney MF, Spindler J, Wiegand A, Chertova E, Roser JD, Estes JD, Hao XP, Trubey CM, Lara A, Lee K, Chaipan C, Bess JW, Jr, Nagashima K, Keele BF, Macallister R, Smedley J, Pathak VK, Kewalramani VN, Coffin JM, Lifson JD. 2012. Restricted replication of xenotropic murine leukemia virus-related virus in pigtailed macaques. J. Virol. 86:3152-3166.
41. Zhang A, Bogerd H, Villinger F, Das Gupta J, Dong B, Klein EA, Hackett J, Jr, Schochetman G, Cullen BR, Silverman RH. 2011. In vivo hypermutation of xenotropic murine leukemia virus-related virusDNAin peripheral blood mononuclear cells of rhesus macaque by APOBEC3 proteins. Virology 421:28-33.
42. Weiss RA. 2010. A cautionary tale of virus and disease. BMC Biol. 8:124. doi:10.1186/1741-7007-8-124.
43. Chaipan C, Dilley KA, Paprotka T, Delviks-Frankenberry KA, Venkatachari NJ, Hu WS, Pathak VK. 2011. Severe restriction of xenotropic murine leukemia virus-related virus replication and spread in cultured human peripheral blood mononuclear cells. J. Virol. 85:4888-4897.
44. Paprotka T, Venkatachari NJ, Chaipan C, Burdick R, Delviks-Frankenberry KA, Hu WS, Pathak VK. 2010. Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs. J. Virol. 84:5719 -5729.
45. Janini M, Rogers M, Birx DR, McCutchan FE. 2001. Human immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4(+) T cells. J. Virol. 75:7973-7986.
46. Kieffer TL, Kwon P, Nettles RE, Han Y, Ray SC, Siliciano RF. 2005. G¡A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo. J. Virol. 79:1975-1980.
47. Nishimura Y, Igarashi T, Haigwood NL, Sadjadpour R, Donau OK, Buckler C, Plishka RJ, Buckler-White A, Martin MA. 2003. Transfer of neutralizing IgG to macaques 6 h but not 24 h after SHIV infection confers sterilizing protection: implications for HIV-1 vaccine development. Proc. Natl. Acad. Sci. U. S. A. 100:15131-15136.
48. Putkonen P, Thorstensson R, Ghavamzadeh L, Albert J, Hild K, Biberfeld G, Norrby E. 1991. Prevention of HIV-2 and SIVsm infection by passive immunization in cynomolgus monkeys. Nature 352:436-438.
49. Cornetta K, Moen RC, Culver K, Morgan RA, McLachlin JR, Sturm S, Selegue J, London W, Blaese RM, Anderson WF. 1990. Amphotropic murine leukemia retrovirus is not an acute pathogen for primates. Hum. Gene Ther. 1:15-30.
50. Cornetta K, Morgan RA, Gillio A, Sturm S, Baltrucki L, O'Reilly R, Anderson WF. 1991. No retroviremia or pathology in long-term follow-up of monkeys exposed to a murine amphotropic retrovirus. Hum. Gene Ther. 2:215-219.
51. Erlwein O, Robinson MJ, Dustan S, Weber J, Kaye S, McClure MO. 2011. DNA extraction columns contaminated with murine sequences. PLoS One 6:e23484. doi:10.1371/journal.pone.0023484.
52. Hue S, Gray ER, Gall A, Katzourakis A, Tan CP, Houldcroft CJ, McLaren S, Pillay D, Futreal A, Garson JA, Pybus OG, Kellam P, Towers GJ. 2010. Disease-associatedXMRVsequences are consistent with laboratory contamination. Retrovirology 7:111. doi:10.1186/1742-4690-7 -111.